News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schreiber Christopher C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 10/15/2021 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 04/21/2021 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 46,113 shares
@ $4.94, valued at
$227.8k
Exercised 131,750 restricted stock units
@ $0 |
|
| 09/11/2020 |
4
| Schreiber Christopher C (Exec. Chairman and President) has filed a Form 4 on Akers Biosciences, Inc.|
Txns:
| Granted 263,500 restricted stock units
@ $0 |
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2019 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on Akers Biosciences, Inc.|
Txns:
| Granted 124,827 restricted stock units
@ $0 |
|
|
|